COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIA
- 1 October 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8461) , 907-910
- https://doi.org/10.1016/s0140-6736(85)90848-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.BMJ, 1984
- Treatment of hypercalcaemia associated with malignancy.BMJ, 1984
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Therapy of malignancy-associated hypercalcemia: 1983The American Journal of Medicine, 1983
- Comparative study of available medical therapy for hypercalcemia of malignancyThe American Journal of Medicine, 1983
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyThe American Journal of Medicine, 1982
- Predictive Value of Derived Calcium Figures Based on the Measurement of Ionised CalciumAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1981
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Treatment of hypercalcemia. Comparison of intravenously administered phosphate, sulfate, and hydrocortisoneArchives of internal medicine (1960), 1972
- Mithramycin treatment of hypercalcemiaCancer, 1970